IGMS - Prakiraan volume dodolan igmbio.com

IGM Biosciences, Inc. (IGMS) - logo korporat

IGM Biosciences, Inc. (IGMS) is developing unique IgM antibody-based medicines, laying the foundation for future partner payments. The projected sales volume illustrates the market response to these achievements, where the current status is 0.15. Its own cGMP facility in California ensures stability. Meanwhile, the potential in treating autoimmune pathologies is only beginning to emerge, and the liquidity for research is already priced into the quotes.

IGMS - Dodolan mangsa ngarep perusahaan IGM Biosciences, Inc. ing rentang 04.07.2022 - 24.08.2025

Rincian metrik lan analitis perusahaan IGM Biosciences (IGMS)

- nilai saham lan prakiraan konsensus rega:
Pambiji fundamental:IGM Bio
Produk mawa merek igmbio.com

This indicator identifies systemic degradation or business growth potential, eliminating the illusion of an undervalued asset. Analyzing the company's projected sales allows for a comparison of market demand against actual logistical costs. The calculation is based on the extrapolation of current commercial prospects and expected revenue. This is critical for IGM Biosciences, Inc. (IGMS), as it monetizes colossal R&D expenditures on the development of IgM antibodies. The metric confirms the long-term efficiency of the proprietary platform.

Perusahaan pesaing

Prakiraan pendapatan perusahaan Argenx (ARGX)|BioNTech - Prakiraan pendapatan perusahaan|Prakiraan volume dodolan ABVX (Abivax)|ADMA Bio (ADMA) - Volume dodolan sing dikarepake perusahaan|PTGX - Prakiraan pendapatan perusahaan|Dodolan mangsa ngarep perusahaan immunovant.com IMVT|KNSA: Prakiraan volume dodolan|Grifols - Pendapatan mangsa ngarep perusahaan|ADPT (Adaptive Biotech) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan CLDX|Prakiraan volume dodolan AUPH|Volume dodolan mangsa ngarep perusahaan biocryst.com BCRX|Vera Therapeutics - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume pendapatan perusahaan DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV - Prakiraan volume dodolan|ABCL: Prakiraan pendapatan perusahaan|Tourmaline Bio, Inc. (TRML) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan precigen.com (PGEN)|PHAR (pharming.com) - Prakiraan volume dodolan|NKTR (Nektar Therapeutics Inc.) - Prakiraan volume pendapatan perusahaan|Prakiraan volume dodolan UPB|ZBIO - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan IMNM (immunome.com)|Gossamer Bio, Inc. - Prakiraan pendapatan perusahaan|KalVista Pharmaceuticals, Inc. - Prakiraan volume dodolan|SEPN (Septerna) - Prakiraan pendapatan perusahaan|Pieris Corp (PVLA) - Prakiraan pendapatan perusahaan|SVRA - Dodolan mangsa ngarep perusahaan|RIGL (rigel.com) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan ANAB (AnaptysBio, Inc.)|Prakiraan volume dodolan ATXS|enGene Holdings Inc (ENGN) - Prakiraan dodolan perusahaan|Prakiraan volume dodolan RAPT (RAPT Therapeutics Inc.)|JBIO (Aerovate) - Pendapatan sing dikarepake perusahaan|ACRS: Volume dodolan mangsa ngarep perusahaan|KYTX - Prakiraan volume dodolan|TLSA: Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cabaletta Bio, Inc|Prakiraan pendapatan perusahaan Ventyx Biosciences, Inc|THTX: Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan AVTX (Avalo Therapeutics, Inc)|Volume dodolan mangsa ngarep perusahaan Eledon Pharmaceuticals ELDN|Prakiraan pendapatan perusahaan Agenus, Inc. AGEN|Prakiraan volume dodolan Climb Bio Inc. CLYM|ZURA - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan ATYR|ADAG (Adagene Inc.) - Volume dodolan mangsa ngarep perusahaan|ImageneBio Inc (IMA) - Prakiraan volume dodolan|Prakiraan pendapatan perusahaan Shattuck Therapeutics|Volume dodolan mangsa ngarep perusahaan equilliumbio.com (EQ)|Prakiraan volume dodolan CNTB|Dodolan mangsa ngarep perusahaan Immunic Therapeutics|Prakiraan volume dodolan ATRA (Atara Biotherapeutics, Inc.)|IFRX - Volume dodolan mangsa ngarep perusahaan|Pendapatan mangsa ngarep perusahaan X4 Pharmaceuticals, Inc. (XFOR)|ACET (adicetbio.com) - Prakiraan pendapatan perusahaan|CELU: Prakiraan volume dodolan|INMB - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Barinthus Biotherapeutics plc|KZR: Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan SABS|AKTX (Akari Therapeutics Plc) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan ENLV (Enlivex Therapeutics Ltd)|q32bio.com - Prakiraan pendapatan perusahaan|GOVX: Volume dodolan mangsa ngarep perusahaan|edesabiotech.com (EDSA) - Volume dodolan mangsa ngarep perusahaan|IBIO: Prakiraan volume dodolan|CARM - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan XTLB|Volume dodolan mangsa ngarep perusahaan boltbio.com (BOLT)|Prakiraan pendapatan perusahaan HCW Biologics Inc (HCWB)|Prakiraan volume dodolan Aptevo Therapeutics, Inc. (APVO)|Prakiraan pendapatan perusahaan aimimmuno.com AIM|Pendapatan mangsa ngarep perusahaan ADTX|GRI Bio Corporation - Prakiraan volume dodolan|XORTX Corp (XRTX) - Volume dodolan mangsa ngarep perusahaan|HIND (Vyome Holdings Inc.) - Volume dodolan mangsa ngarep perusahaan|revbiosciences.com (REVB) - Prakiraan volume dodolan|INDP (Indaptus Corp) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Scinai Immunotherapeutics Ltd (SCNI)|Prakiraan pendapatan perusahaan CalciMedica Inc (CALI)|AFMD (Affimed NV) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan ALLK (Allakos Inc.)|Prakiraan volume dodolan HOOKIPA HOOK|ITOS: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Ocean Biomedical|TCBP: Prakiraan volume dodolan|Third Harmonic Bio, Inc - Pendapatan mangsa ngarep perusahaan